Bank of New York Mellon
LFST icon

Bank of New York Mellon’s Lifestance Health LFST Stock Holding History

Bank of New York Mellon’s Portfolio LFST Stock Details LFST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.6M Buy
1,085,487
+626,742
+137% +$4.84M ﹤0.01% 1948
2026
Q1 		$2.92M Sell
458,745
-2,180
-0.5% -$15.2K ﹤0.01% 2615
2025
Q4 		$3.24M Buy
460,925
+60,251
+15% +$364K ﹤0.01% 2573
2025
Q3 		$2.2M Buy
400,674
+4,385
+1% +$21.5K ﹤0.01% 2748
2025
Q2 		$2.05M Buy
396,289
+502
+0.1% +$3.01K ﹤0.01% 2737
2025
Q1 		$2.64M Sell
395,787
-5,029
-1% -$38.2K ﹤0.01% 2557
2024
Q4 		$2.95M Buy
400,816
+15,365
+4% +$110K ﹤0.01% 2573
2024
Q3 		$2.7M Sell
385,451
-65,651
-15% -$395K ﹤0.01% 2610
2024
Q2 		$2.21M Buy
451,102
+15,309
+4% +$92.3K ﹤0.01% 2739
2024
Q1 		$2.69M Sell
435,793
-14,014
-3% -$94.4K ﹤0.01% 2611
2023
Q4 		$3.52M Buy
449,807
+14,660
+3% +$94.5K ﹤0.01% 2545
2023
Q3 		$2.99M Sell
435,147
-6,315
-1% -$51.2K ﹤0.01% 2579
2023
Q2 		$4.03M Buy
441,462
+76,295
+21% +$634K ﹤0.01% 2443
2023
Q1 		$2.71M Buy
365,167
+4,672
+1% +$25.9K ﹤0.01% 2620
2022
Q4 		$1.78M Sell
360,495
-6,362
-2% -$39.3K ﹤0.01% 2915
2022
Q3 		$2.43M Buy
366,857
+83,267
+29% +$581K ﹤0.01% 2720
2022
Q2 		$1.58M Buy
283,590
+56,417
+25% +$432K ﹤0.01% 2966
2022
Q1 		$2.3M Buy
227,173
+68,759
+43% +$603K ﹤0.01% 2853
2021
Q4 		$1.51M Buy
158,414
+42,119
+36% +$447K ﹤0.01% 3151
2021
Q3 		$1.69M Buy
+116,295
New +$2.24M ﹤0.01% 3092

Other funds holding LFST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SP
Summit Partners Boston, Massachusetts $609M AUM 7.66% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bank of New York Mellon's LFST Position: Q2 2026 in Review

Bank of New York Mellon increased its Lifestance Health (LFST) stake by 137% in Q2 2026, buying an estimated $4.84M and bringing the position to 1,085,487 shares worth $11.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1948.

Bank of New York Mellon first reported a position in LFST in Q3 2021 and has held it in 20 quarters since. 121 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

  • Bank of New York Mellon held 1,085,487 shares of Lifestance Health worth $11.6M as of Q2 2026.
  • Bank of New York Mellon bought 626,742 Lifestance Health shares in Q2 2026, an estimated $4.84M.
  • Lifestance Health made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #1948 holding.
  • Bank of New York Mellon first reported a position in Lifestance Health in Q3 2021 and has held it in 20 quarters since.
  • 121 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.